Introducing RxEvent
Play RxEvent Video
RxEvent is streamlining the adverse drug event reporting process benefiting physicians, patients and the FDA – turning lemons into lemonADE for manufacturers. Watch this video to learn more.
For Manufacturers
PDR Network ensures compliance with end-to-end distribution programs for FDA-approved Alerts, patient safety communications, recalls and REMS programs. For more information, visit our Services page.
For Physicians/Prescribers
PDR Network compliance offers timely and efficient access to FDA-approved drug information and FDA-required safety Alerts, improving patient safety and reducing professional medical liability.
PDR Helps Doctors Help Patients with New Digital Service
PDR Network today announced the launch of the PDR® Patient Resource Guide for Physicians – a first-of-its-kind digital database for physicians to access and distribute resources to their patients in order to help patients understand, manage and pay for their medications. The PDR® Patient Resource Guide for Physicians provides physicians with a single digital resource available online, via mobile or within their Electronic Health Record (EHR) system – helping physicians help their patients understand, afford and stay on their medications. Learn More
What’s New
PDR Network Appoints Richard Altus as Company President
PDR Network today announced that Richard Altus has joined the Company as President. He will be responsible for the oversight of all Company operations and will help lead PDR Network through its next phase of growth. Read more...
About RxEvent
RxEvent is a new service to collect and distribute adverse drug events (ADEs) from a single portal within prescriber workflow. Roughly half a million ADEs are reported annually and studies show as few as 1 in 10 are actually reported, largely due to the time-consuming, inefficient reporting processes. RxEvent--available within EHRs and directly at RxEvent.org--was developed to improve the cost-efficiency of reporting for manufacturers, the convenience for physicians and the quality of reports to the FDA.
